Form 4: Arvinas CFO Sells Shares for Tax Withholding

Arvinas Chief Financial Officer Andrew Saik sold 5,696 shares of common stock to cover tax withholding obligations related to restricted stock units.

Summary

• Andrew Saik, Chief Financial Officer of Arvinas, Inc., reported a transaction on June 24, 2026.
• The transaction involved the sale of 5,696 shares of common stock.
• The sale was executed automatically by the issuer to cover tax withholding obligations.
• These obligations arose from the vesting and settlement of 25% of restricted stock units (RSUs) granted on June 24, 2024.
• The sale was made pursuant to a pre-arranged, durable sale instruction intended to satisfy Rule 10b5-1(c) affirmative defense conditions.
• This transaction does not represent a discretionary trade by the reporting person.
• Following the transaction, Saik beneficially owns 187,432 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale can sometimes be perceived negatively, this transaction is clearly defined as an automatic, pre-planned event for tax purposes, mitigating concerns about discretionary selling based on non-public information.

Positives

• The sale was part of a pre-planned, automatic process to cover tax liabilities, indicating adherence to a structured financial plan.
• The transaction was executed under a Rule 10b5-1(c) plan, which is designed to provide an affirmative defense against insider trading allegations.
• The sale was not a discretionary trade, suggesting it was not based on material non-public information.

Negatives

• A portion of the reporting person's equity award was sold, which could be perceived negatively by some investors, although it was for tax purposes.

Risks

• While this specific transaction is automated and planned, future sales by insiders, if not managed under similar plans, could pose a risk if perceived as opportunistic.
• The vesting of RSUs and subsequent tax withholding sales are a normal part of executive compensation but can lead to a reduction in direct insider holdings if not reinvested.

Future Outlook

The filing does not contain forward-looking statements or guidance. It solely reports a past transaction.

Management Comments

• The sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of 25% of the reporting person's restricted stock units (RSUs) granted on June 24, 2024, pursuant to a durable sale instruction.
• The sale does not represent a discretionary trade.

Industry Context

StockSavvy.ai notes that insider sales for tax withholding are a common and expected event for executives receiving equity compensation. The use of a Rule 10b5-1 plan for this transaction is a positive indicator of compliance and good governance practices within the biopharmaceutical sector, where equity-based compensation is prevalent.

Corporate Governance

Stakeholder Impact

• Shareholders: The sale is for tax withholding and not a discretionary trade, so it should not significantly impact investor sentiment negatively. The company's overall financial health and strategic direction remain the primary drivers.
• Employees: This transaction is related to executive compensation and does not directly impact other employees.
• Management: Andrew Saik's direct beneficial ownership of Arvinas stock is reduced by the sale, but the underlying equity award was settled.

Next Steps

• Continued adherence to the Rule 10b5-1 plan for any future transactions.
• Monitoring of future equity vesting and settlement events for Andrew Saik.

Key Dates

Keywords

Form 4, Insider Transaction, Arvinas, ARVN, Andrew Saik, Chief Financial Officer, Stock Sale, Tax Withholding, Restricted Stock Units, RSUs, Rule 10b5-1, Beneficial Ownership